Cagrilintide

Dual GIP/GLP-1 receptor agonist produced at Helix Peptide GMP suites with HPLC and MS identity confirmation on every lot.

Triple agonist peptide for advanced metabolic research, available in research and GMP grades with custom fill weights.

Fragment peptide derived from human growth hormone, synthesized with acetylation and amidation for enhanced stability.

Helix Peptide supplies semaglutide API with full batch traceability and COA documentation for qualified pharmaceutical partners.